YOLFTbeta
Prenetics Global Ltd

Prenetics Global Ltd

PRE · NASDAQ · Consumer Defensive / Packaged Foods

16.51USD-0.21 (-1.26%)

Price History

Full chart

Market Stats

Previous Close16.72
Open16.47
Day Range16.30 – 17.74
52-Week Range11.37 – 27.24
Volume151.79K
Market Cap385.42M
P/E (TTM)0.00
Forward P/E0.00
EPS-3.46
Dividend Yield0.00%
Beta0.31
50-Day Avg21.52
200-Day Avg19.05

About

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Sheng Wu Yeung
  • Employees98
  • HeadquartersUnit 703-706, K11 Atelier King?s Road, Quarry Bay, Hong Kong, USA
  • Websitehttps://www.prenetics.com

Leadership

  • Mr. Sheng Wu YeungCo-Founder, Chairperson & CEO · b. 1979
  • Ms. Samantha KwokChief of Staff & VP of People & Operations
  • Mr. Brian ChaeGeneral Counsel
  • Dr. Senthil Kumar Sundaram M.D.Chief Clinical Officer · b. 1974
  • Mr. Brian J. RosinChief Financial Officer of U.S.

Financials

Income Statement

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.53B1.89B2.67B3.87B4.17B4.21B4.19B4.15B4.00B5.33B5.90B5.40B5.56B5.59B6.48B5.48B9.23M65.18M12.53M13.16M21.74M30.62M92.39M
Growth (%)-+24.21%+40.89%+45.06%+7.74%+0.79%-0.43%-0.88%-3.59%+33.30%+10.66%-8.60%+3.11%+0.49%+15.87%-15.44%-99.83%+605.93%-80.77%+5.04%+65.17%+40.83%+201.72%
Cost of Revenue1.40B1.72B2.43B3.37B3.65B4.21B3.27B3.26B3.87B3.56B4.70B5.74B4.15B4.68B5.12B4.76B6.52M38.83M8.93M9.55M12.91M15.22M43.60M
Gross Profit127.28M177.43M236.34M498.19M524.07M-917.26M952.10M106.85M1.77B1.16B-1.41B860.40M1.36B668.70M2.72M26.34M3.60M3.62M8.83M15.40M48.79M
Gross Margin8.34%9.36%8.85%12.86%12.56%-21.91%22.94%2.67%33.17%19.64%-25.34%15.39%21.02%12.21%29.41%40.42%28.75%27.48%40.61%50.29%52.81%
Operating Expense26.03M26.04M000-00040.28M68.55M-31.80M27.18M27.49M26.59M23.52M27.34M60.26M69.64M60.74M63.54M86.92M
Operating Income101.25M151.39M236.34M498.19M524.07M-917.26M952.10M106.85M1.73B1.09B-1.38B833.23M1.33B642.11M-20.80M-995.13K-56.66M-66.02M-51.91M-48.14M-38.13M
Operating Margin6.64%7.99%8.85%12.86%12.56%-21.91%22.94%2.67%32.41%18.48%-24.77%14.91%20.59%11.72%-225.31%-1.53%-452.11%-501.53%-238.73%-157.23%-41.27%
EBITDA-----------------18.57M-1.42M-209.16M-218.04M-47.90M-51.57M-32.19M
EBITDA Margin-----------------201.11%-2.17%-1668.95%-1656.31%-220.29%-168.41%-34.84%
Net Income142.31M-190.30M467.68M492.35M-749.33M717.81M46.57M1.54B852.55M-1.13B664.01M1.05B104.38M-20.14M-1.94M-174.01M-190.45M-62.72M-46.30M-37.71M
Net Income Margin9.33%-7.13%12.08%11.80%-17.89%17.29%1.16%28.81%14.44%-20.40%11.88%16.29%1.91%-218.15%-2.98%-1388.44%-1446.78%-288.48%-151.22%-40.82%
R&D----------------2.99M2.78M6.39M5.99M11.66M10.92M5.13M
R&D as % of Total Revenue----------------32.38%4.27%51.00%45.50%53.64%35.67%5.55%
Interest Expense000000000000000069.39K59.57K42.23K242.00K119.66K203.00K241.00K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.75%0.09%0.34%1.84%0.55%0.66%0.26%

Balance Sheet

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.09B7.17B8.74B10.90B12.51B13.74B14.95B16.04B16.28B23.73B23.36B22.86B22.98B23.04B22.27B21.41B29.69M78.88M148.51M312.13M254.17M213.57M203.52M
Total Liabilities4.01B5.42B6.66B8.31B9.16B10.65B11.16B11.72B12.08B16.09B16.16B16.39B16.05B16.27B15.17B14.50B12.83M47.88M549.40M68.67M44.01M42.23M29.01M
Total Equity2.09B1.75B2.08B2.59B3.35B3.09B3.79B4.32B4.20B7.65B7.21B6.47B6.93B6.77B7.10B6.90B16.91M31.08M-400.81M237.06M206.36M170.39M174.60M
Cash434.03M451.61M710.64M558.69M436.00M1.00B988.79M654.89M838.28M738.31M2.11B1.34B1.12B1.50B1.31B1.58B11.52M14.49M35.29M146.66M45.71M52.25M32.13M
Total Debt----------------1.46M17.14M491.67M6.65M2.37M5.77M2.20M
Net Debt-----------------10.07M2.65M456.38M-140.01M-43.34M-46.48M-29.93M

Cash Flow

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-363.76M687.24M1.15B1.26B1.03B491.77M1.23B1.16B1.10B1.23B573.63M693.29M827.27M852.60M318.81M-1.88M-2.88M13.42M14.51M-13.76M-28.87M-21.81M
Investing Cash Flow104.00M---------1.10B--417.99M-295.27M-4.60M-5.97M-22.02M-46.14M-82.95M38.54M-35.79M
Financing Cash Flow-313.29M15.83M--383.52M-----------569.14K11.84M29.32M143.32M-4.70M-3.34M37.54M
Capital Expenditure0000000000000000373.86K3.06M11.41M6.34M911.81K1.06M208.00K
Free Cash Flow-----------------2.26M-5.94M2.00M8.17M-14.68M-29.94M-22.02M
Dividends Paid71.22M75.15M78.42M93.42M92.27M118.92M125.42M130.93M134.63M151.85M192.16M205.78M217.62M200.08M190.96M190.34M0000000
FCF to OCF----------------119.85%206.26%14.94%56.30%106.62%103.69%100.95%
Dividend Paid to FCF----------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateJun 29, 2021Aug 16, 2021Nov 15, 2021Mar 4, 2022Jun 6, 2022Sep 9, 2022Nov 10, 2022Mar 14, 2023Jun 5, 2023Sep 15, 2023Nov 20, 2023Mar 12, 2024May 1, 2024Jun 30, 2024Nov 27, 2024Mar 5, 2025Jun 12, 2025Sep 12, 2025Nov 10, 2025Feb 18, 2026Jun 10, 2026Aug 18, 2026Nov 9, 2026
EPS Estimate0.000.00---19.20-0.62-1.95-1.50-0.75-0.05-1.20-0.05-4.80-0.93-0.86-0.72-0.80-0.71-0.55-0.49-0.49-0.32-0.73
EPS Actual0.00-0.13-0.090.14-33.150.044.460.15-1.05-0.10-1.20-1.57-5.30-0.88-0.84-1.29-0.80-0.94-0.53-0.27-0.56-0.53-
Surprise-----72.66%106.45%328.72%110.00%-40.00%-100.00%0.00%-3040.00%-10.42%5.38%2.33%-79.17%0.00%-32.39%3.64%44.90%-14.29%-65.63%-
Timing---After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-Pre-market-Pre-marketPre-market-Pre-market-Pre-market-

Key Statistics & Ratios

Market Cap385.42M
Enterprise Value171.15M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales2.49
Price / Book1.30
EPS-3.46
Book Value5.39
Revenue (TTM)154.59M
Gross Profit (TTM)89.30M
EBITDA-53.97M
Profit Margin-30.40%
Operating Margin-45.13%
Return on Equity-47.01%
Return on Assets-18.95%
Shares Outstanding15.20M
Shares Float12.79M
Beta0.31
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 35.86
  • Strong Buy
    1

Ownership Breakdown

Institutions
7.88%
Insiders
14.54%
Retail / Other
77.58%

Top Institutional Holders

  • Prudential Corp PLC
    427.96K2.56%
  • Aspex Management (HK) Ltd
    346.15K2.07%
  • Prospect Capital Advisors, LLC
    235.80K1.41%
  • The Goldman Sachs Group Inc
    193.58K1.16%
  • Millennium Management LLC
    126.09K0.75%
  • Tenzing Global Management LLC
    125.00K0.75%
  • Wells Fargo & Co
    84.81K0.51%
  • Marshall Wace Asset Management Ltd
    73.33K0.44%
  • Jane Street Group LLC
    42.19K0.25%
  • Nomura Holdings Inc
    42.10K0.25%
  • 683 Capital Management LLC
    40.00K0.24%
  • XTX Topco Ltd
    33.42K0.20%
  • BlackRock Inc
    33.25K0.20%
  • Susquehanna International Group, LLP
    33.12K0.20%
  • Renaissance Technologies Corp
    31.32K0.19%
  • HRT FINANCIAL LLC
    28.94K0.17%
  • MY PURPOSEFUL WEALTH CORP
    28.15K0.17%
  • UBS Group AG
    26.77K0.16%
  • Qube Research & Technologies
    19.13K0.11%
  • Morgan Stanley - Brokerage Accounts
    17.09K0.10%

Stock Splits

  • Nov 14, 20231:15
  • May 18, 2022129:100